Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)
CUSIP: 08205P209
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.0001
- Shares outstanding
- 35,393,481
- Total 13F shares
- 18,997,897
- Share change
- +5,072,874
- Total reported value
- $240,166,135
- Price per share
- $12.63
- Number of holders
- 30
- Value change
- +$64,576,294
- Number of buys
- 22
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 08205P209?
CUSIP 08205P209 identifies BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 08205P209:
Top shareholders of BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
25%
|
8,829,053
|
$81,138,997 | — | 30 Sep 2024 | |
| HBM Healthcare Investments (Cayman) Ltd. |
13D/G
|
— |
4.5%
|
1,041,669
|
$14,156,282 | $0 | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.3%
|
796,644
|
$8,093,903 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.5%
|
876,523
|
$8,033,333 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.4%
|
841,395
|
$7,732,420 | — | 30 Sep 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.4%
|
838,095
|
$7,702,093 | — | 30 Sep 2024 | |
| AWM Investment Company, Inc. |
13F
|
Company |
1.8%
|
625,000
|
$5,743,750 | — | 30 Sep 2024 | |
| Steven Michael Oliveira |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,000,000
|
$3,044,300 | — | 28 Apr 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.77%
|
272,817
|
$2,507,188 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.6%
|
213,067
|
$1,958,086 | — | 30 Sep 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.33%
|
116,535
|
$1,070,957 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
83,987
|
$772,125 | — | 30 Sep 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.17%
|
60,000
|
$551,400 | — | 30 Sep 2024 | |
| Lion Point Capital, LP |
13F
|
Company |
0.11%
|
39,000
|
$358,410 | — | 30 Sep 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.08%
|
29,800
|
$273,862 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.08%
|
28,238
|
$259,507 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
24,775
|
$227,682 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.04%
|
14,879
|
$136,738 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
14,244
|
$130,902 | — | 30 Sep 2024 | |
| GAMMA Investing LLC |
13F
|
Company |
0.02%
|
6,540
|
$60,103 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,924
|
$17,681 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,324
|
$12,168 | — | 30 Sep 2024 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
610
|
$5,606 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
230
|
$2,114 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
186
|
$1,709 | — | 30 Sep 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
89
|
$818 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
68
|
$625 | — | 30 Sep 2024 |
Institutional Holders of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) as of Q4 2024
As of 31 Dec 2024,
Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,997,897 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Nantahala Capital Management, LLC, VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, INFINITUM ASSET MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock, Inc..
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
25
Q4 2024 holders
30
Holder diff
5
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.